Incyte (1INCY) Stock Forecast & Price Target
1INCY Analyst Ratings
Moderate Buy
11Buy11Hold0Sell
Based on 22 analysts giving stock ratings to Incyte in the past 3 months
1INCY Stock 12 Month Forecast
Average Price Target
EUR 120.00▲(11.11% Upside)Based on 22 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is EUR 120.00 with a high forecast of EUR 140.18 and a low forecast of EUR 92.86. The average price target represents a 11.11% change from the last price of EUR 108.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 140.18
AverageEUR 120.00
LowEUR 92.86
Highest Price TargetHighestEUR 140.18Average Price TargetEUR 120.00Lowest Price TargetLowestEUR 92.86
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Newman | Canaccord Genuity | EUR 135.71 | buy | 25.66%Upside | Reiterated | 10/30/26 | ||
| Mitchell Kapoor | H.C. Wainwright | EUR 135.71 | buy | 25.66%Upside | Reiterated | 10/30/26 | ||
| Etzer Darout | Barclays | EUR 124.11→EUR 127.68 | buy | 18.22%Upside | Reiterated | 10/30/26 | ||
| Ashwani Verma | UBS | EUR 113.39 | hold | 4.99%Upside | Reiterated | 10/30/26 | ||
 Chris YuNot Ranked | Morgan Stanley | EUR 106.25→EUR 103.57 | hold | -4.10%Downside | Assigned | 10/30/26 | ||
| Gavin Clark-Gartner | Evercore ISI | EUR 111.61→EUR 113.39 | hold | 4.99%Upside | Reiterated | 10/30/26 | ||
| Stephen Willey | Stifel Nicolaus | EUR 140.18 | buy | 29.79%Upside | Reiterated | 10/30/26 | ||
| Michael Schmidt | Guggenheim | EUR 135.71 | buy | 25.66%Upside | Reiterated | 10/29/26 | ||
| Brian Abrahams | RBC Capital | EUR 101.78→EUR 104.46 | hold | -3.27%Downside | Assigned | 10/29/26 | ||
| Jay Olson | Oppenheimer | EUR 107.14→EUR 128.57 | buy | 19.05%Upside | Upgraded | 10/29/26 | ||
| Derek Archila | Wells Fargo | EUR 114.28→EUR 113.39 | hold | 4.99%Upside | Reiterated | 10/29/26 | ||
| Unknown AnalystNot Ranked | Cantor Fitzgerald | ― | hold | ― | Reiterated | 10/29/26 | ||
| Srikripa Devarakonda | Truist Financial | EUR 102.68 | hold | -4.93%Downside | Reiterated | 10/27/26 | ||
| Tazeen Ahmad | Bank of America Securities | EUR 125.00 | buy | 15.74%Upside | Reiterated | 10/26/26 | ||
| Evan Seigerman | BMO Capital | EUR 116.07 | hold | 7.47%Upside | Reiterated | 10/26/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Newman | 10/30/26 | EUR 135.71 | buy | 25.66%Upside | Reiterated | Canaccord Genuity | ||
| Mitchell Kapoor | 10/30/26 | EUR 135.71 | buy | 25.66%Upside | Reiterated | H.C. Wainwright | ||
| Etzer Darout | 10/30/26 | EUR 124.11→EUR 127.68 | buy | 18.22%Upside | Reiterated | Barclays | ||
| Ashwani Verma | 10/30/26 | EUR 113.39 | hold | 4.99%Upside | Reiterated | UBS | ||
| Chris YuNot Ranked | 10/30/26 | EUR 106.25→EUR 103.57 | hold | -4.10%Downside | Assigned | Morgan Stanley | ||
| Gavin Clark-Gartner | 10/30/26 | EUR 111.61→EUR 113.39 | hold | 4.99%Upside | Reiterated | Evercore ISI | ||
| Stephen Willey | 10/30/26 | EUR 140.18 | buy | 29.79%Upside | Reiterated | Stifel Nicolaus | ||
| Michael Schmidt | 10/29/26 | EUR 135.71 | buy | 25.66%Upside | Reiterated | Guggenheim | ||
| Brian Abrahams | 10/29/26 | EUR 101.78→EUR 104.46 | hold | -3.27%Downside | Assigned | RBC Capital | ||
| Jay Olson | 10/29/26 | EUR 107.14→EUR 128.57 | buy | 19.05%Upside | Upgraded | Oppenheimer | ||
| Derek Archila | 10/29/26 | EUR 114.28→EUR 113.39 | hold | 4.99%Upside | Reiterated | Wells Fargo | ||
| Unknown AnalystNot Ranked | 10/29/26 | ― | hold | ― | Reiterated | Cantor Fitzgerald | ||
| Srikripa Devarakonda | 10/27/26 | EUR 102.68 | hold | -4.93%Downside | Reiterated | Truist Financial | ||
| Tazeen Ahmad | 10/26/26 | EUR 125.00 | buy | 15.74%Upside | Reiterated | Bank of America Securities | ||
| Evan Seigerman | 10/26/26 | EUR 116.07 | hold | 7.47%Upside | Reiterated | BMO Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Incyte
3 Months
Success Rate20/26 ratings generated profit
77%
Average Return
+9.83%
Copying Michael Schmidt's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +9.83% per trade.
1 Year
Success Rate19/19 ratings generated profit
100%
Average Return
+31.35%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +31.35% per trade.
2 Years
Success Rate19/19 ratings generated profit
100%
Average Return
+41.44%
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.44% per trade.
1INCY Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 41 | 40 | 40 | 21 | 30 |
| Hold | 28 | 41 | 41 | 29 | 26 |
| Sell | 4 | 3 | 2 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 73 | 84 | 83 | 50 | 56 |
In the current month, 1INCY has received 30 Buy Ratings, 26 Hold Ratings, and 0 Sell Ratings. 1INCY average Analyst price target in the past 3 months is 120.00.
1INCY Financial Forecast
HighEUR 2.75
ConsensusEUR 1.71
LowEUR 1.31
1INCY Earnings Forecast
Next quarter’s earnings estimate for 1INCY is EUR 1.71 with a range of EUR 1.31 to EUR 2.75. The previous quarter’s EPS was -EUR 3.21. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 1.43B
ConsensusEUR 1.38B
LowEUR 1.26B
1INCY Sales Forecast
Next quarter’s sales forecast for 1INCY is EUR 1.38B with a range of EUR 1.26B to EUR 1.43B. The previous quarter’s sales results were EUR 1.39B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1INCY Stock Forecast FAQ
What is IT:1INCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Incyte’s 12-month average price target is €120.00.
What is IT:1INCY’s upside potential, based on the analysts’ average price target?
Incyte has 11.11% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Incyte a Buy, Sell or Hold?
Incyte has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 11 hold ratings and 0 sell ratings.
What is Incyte’s share price target?
The average share price target for Incyte is €120.00. This is based on 22 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €140.18, and the lowest forecast is €92.86. The average share price target represents a 11.11% increase from the current price of €108.
What do analysts say about Incyte?
Incyte’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Street analysts.
How can I buy shares of Incyte?
To buy shares of IT:1INCY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.